Kiribati vs Yemen: Tuberculosis patients living with HIV receiving antiretroviral therapy
Kiribati
0 patients
in 2021
Yemen
0 patients
in 2020
Kiribati rank
141st
Yemen rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Kiribati
- Yemen
How they compare
Kiribati currently reports 0 patients against 0 patients in Yemen, a difference of 0 patients.
The two have swapped places 2 times across 12 shared years of data; in 2005 it was Yemen ahead.
Kiribati ranks 141st and Yemen ranks 141st of 183 countries.
Yemen has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kiribati | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0 patients | 0 patients | — |
| 2010s | 0.2857 patients | 6 patients | 5.71 patients | Yemen |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Kiribati or Yemen?
- Kiribati, at 0 patients against 0 patients in Yemen as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Kiribati and Yemen?
- 0 patients, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Yemen?
- 12 years are reported by both, from 2005 to 2020.
- How do Kiribati and Yemen rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Kiribati ranks 141st and Yemen ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.